Home-Based Cognitive Training for Post-Traumatic Epilepsy
(HOBSCOTCHPTE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a home-based program can improve life quality and brain function for people with post-traumatic epilepsy (PTE). The program, called HOBSCOTCH-PTE (Home-Based Self-Management and Cognitive Training Changes Lives in post-traumatic epilepsy), includes virtual sessions and phone calls that teach skills for better symptom management. It also examines how this program might ease the burden on caregivers supporting someone with PTE. People with PTE who experience memory issues and have consistent internet and phone access could be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance daily life for those with PTE.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires no changes in your antiepileptic and antidepressant medication regimen for 1 month before joining. Brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable.
What prior data suggests that the HOBSCOTCH-PTE program is safe for participants and caregivers?
Research has shown that HOBSCOTCH-PTE is based on an existing program called HOBSCOTCH, which helps people with epilepsy manage memory and attention problems. This program has been used successfully in the past without major safety concerns. The current study aims to adapt it specifically for people with post-traumatic epilepsy (PTE) and their caregivers.
The original HOBSCOTCH program is known to be safe and well-tolerated. Since HOBSCOTCH-PTE is an adaptation, it is expected to be similarly safe. No reports of serious side effects have emerged with the original program. People using it have generally found it helpful and safe.
For caregivers, the program aims to reduce stress and improve their quality of life, highlighting its gentle and supportive nature. Since this trial is not testing a new drug but a behavioral program, the risks are considered low. Participants can feel reassured that the program's main focus is on improving mental skills and quality of life, not introducing new medications.12345Why are researchers excited about this trial?
Unlike standard treatments for post-traumatic epilepsy, which often focus on medication to control seizures, HOBSCOTCH-PTE offers a unique approach by emphasizing cognitive training and self-management. This method is delivered directly to participants' homes through a combination of webcam and telephone sessions, making it accessible and convenient. Researchers are excited because it includes caregivers in the process, offering them tools and relaxation techniques to better support the patient. This holistic approach aims to improve quality of life by addressing the cognitive and emotional challenges associated with epilepsy, beyond just seizure control.
What evidence suggests that the HOBSCOTCH-PTE program could be effective for improving quality of life in post-traumatic epilepsy?
Research shows that HOBSCOTCH-PTE could help people with post-traumatic epilepsy (PTE) live better and think more clearly. In this trial, participants in PTE Participant Group 1 will receive the HOBSCOTCH-PTE intervention immediately, while those in PTE Participant Group 2 will receive it after a 3-month wait. Users of this home-based program have reported improvements in daily life and mental sharpness. Studies also suggest it can ease depression and lift mood. For caregivers, early evidence indicates that HOBSCOTCH-PTE may help lower stress and enhance overall well-being. Caregivers in Group 1 will participate in the program alongside their PTE patients immediately, while those in Caregiver Group 2 will join after a 3-month wait. This program includes both learning and support sessions, which have made daily challenges easier for both patients and caregivers.12356
Who Is on the Research Team?
Barbara Jobst, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Elaine T Kiriakopoulos, MD, MSc
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with post-traumatic epilepsy (PTE), who may have controlled or uncontrolled seizures and memory issues. Participants must not have changed their epilepsy or antidepressant medications in the last month, except for brief pauses for EEG tests. They should be able to read English and have access to a phone and internet.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-HOBSCOTCH Session
Participants attend a pre-HOBSCOTCH session via webcam to prepare for the intervention
HOBSCOTCH-PTE Intervention
Participants receive the HOBSCOTCH-PTE intervention consisting of educational and telephone sessions to improve quality of life and cognitive function
Follow-up
Participants are monitored for changes in quality of life, cognitive function, and caregiver burden post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- HOBSCOTCH-PTE for Caregivers
- Home Based Self-management and Cognitive Training Changes lives in post traumatic epilepsy (HOBSCOTCH-PTE)
HOBSCOTCH-PTE for Caregivers is already approved in United States for the following indications:
- Improvement of quality of life and cognitive function in individuals with post-traumatic epilepsy (PTE)
- Reduction of caregiver burden
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
United States Department of Defense
Collaborator